VASCU-GUARD Peripheral Vascular Patch VG0108NRecalls & reported problems
Synovis Life Technologies, Inc. · VASCU-GUARD Peripheral Vascular Patch is prepared from bovine pericardium which is cross-linked with glutaraldehyde. The pericardium is procured from cattle originating in the United States. VASCU-GUARD Peripheral Vascular Patch is chemically sterilized using ethanol and propylene oxide. VASCU-GUARD Peripheral Vascular Patch has been treated with 1 molar sodium hydroxide for a minimum of 60 minutes at 20 - 25°C. VASCU-GUARD Peripheral Vascular Patch is packaged in a container filled with sterile, non-pyrogenic water containing propylene oxide. The contents of the unopened, undamaged container are sterile. · Class 2 · Implant
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 11
- Deaths reported
- 1
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 11 adverse event reports that list this exact device (DI 00085412530895), received between Aug 22, 2016 and Dec 5, 2024 — classified as 1 death, 2 injuries, 8 malfunctions.
The most frequently reported specific device problem is “Device Contamination with Chemical or Other Material” (8 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Device Contamination with Chemical or Other Material8
- Adverse Event Without Identified Device or Use Problem2
- Positioning Problem1
Patient problems
- No Clinical Signs, Symptoms or Conditions5
- No Patient Involvement3
- Hematoma2
- Hemorrhage/Blood Loss/Bleeding1
- Hypoxia1
- Swelling1
Recent adverse event reports
The 11 most recent of 11 reports, in the reporter's own words as published by the FDA.
MalfunctionDec 5, 2024Device Contamination with Chemical or Other Material; Device Contamination with Chemical or Other Material
IT WAS REPORTED THAT A VASCU-GUARD PERIPHERAL VASCULAR PATCH HAD A FLOATING WHITE SUBSTANCE ON THE SURFACE OF THE LIQUID. THIS WAS FOUND WHEN THE NURSE REMOVED THE JAR LID. THERE WAS NO PATIENT INVOLVEMENT. NO ADDITIONAL INFORMATION IS AVAILABLE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20858252 ↗MalfunctionJan 26, 2023Device Contamination with Chemical or Other Material; Device Contamination with Chemical or Other Material
IT WAS REPORTED THAT A FUNGUS OR HAIR WAS OBSERVED ON A VASCU-GUARD APEX 0.8 X 8. THE ISSUE WAS IDENTIFIED DURING SETUP AND PREPARATION. THE SEAL WAS POPPED OPEN, BUT THE TISSUE WAS NEVER REMOVED FROM THE CONTAINER. THERE WAS NO PATIENT INVOLVEMENT. NO ADDITIONAL INFORMATION IS AVAILABLE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 16247212 ↗MalfunctionJan 4, 2023Device Contamination with Chemical or Other Material; Device Contamination with Chemical or Other Material
IT WAS REPORTED THAT PARTICULATE MATTER (PM) WAS FOUND ON A VASCU-GUARD PERIPHERAL VASCULAR PATCH. THE PM WAS FURTHER DESCRIBED AS, ¿FLUFF ON THE PRODUCT¿. THE PM WAS DISCOVERED DURING SETUP PRIOR TO PATIENT USE. THERE WAS NO PATIENT INVOLVEMENT. NO ADDITIONAL INFORMATION IS AVAILABLE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 16095056 ↗MalfunctionJan 7, 2022Device Contamination with Chemical or Other Material; Device Contamination with Chemical or Other Material
IT WAS REPORTED THAT A VASCU-GUARD APEX 0.8 X 8 HAD PARTICULATE MATTER. THE EVENT WAS FURTHER DESCRIBED AS A FLUFF WAS FOUND ON THE PRODUCT. THIS ISSUE WAS IDENTIFIED DURING SETUP AND PREPARATION PRIOR TO PATIENT USE. AS A RESULT, THE DOCTOR DID NOT USE THE PERIPHERAL VASCULAR PATCH. THERE WAS NO PATIENT INVOLVEMENT. NO ADDITIONAL INFORMATION IS AVAILABLE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 13196923 ↗MalfunctionDec 1, 2021Device Contamination with Chemical or Other Material; Device Contamination with Chemical or Other Material
IT WAS REPORTED THAT A HAIR WAS FOUND IN A VASCU-GUARD PRODUCT. THIS WAS IDENTIFIED BEFORE PATIENT USE. THERE WAS NO PATIENT INVOLVEMENT. NO ADDITIONAL INFORMATION IS AVAILABLE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12910163 ↗InjuryJan 4, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A PATIENT UNDERWENT A CAROTID ARTERY ENDARTERECTOMY SURGERY IN WHICH VASCU-GUARD PATCHES WERE USED. FOLLOWING SURGERY, THE PATIENT WAS TRANSFERRED TO THE CARDIAC CARE UNIT (CCU) WITH NO SIGNS OF HEMATOMA AND A JP DRAIN IN PLACE. APPROXIMATELY FIVE HOURS LATER, THE PATIENT EXPERIENCED BLEEDING AND PRESENTED WITH A DEVIATED TRACHEA, NO STRIDOR WAS NOTED. IT WAS REPORTED 10 MINUTES LATER, THE PATIENT WAS TRANSFERRED TO THE OPERATING ROOM AND WAS INTUBATED. FOLLOWING INTUBATION, ¿VERY LARGE AMOUNT OF BLOOD CLOTS¿ WERE EVACUATED, AND AFTER THE CAROTID ARTERY WAS VISIBLE, THE DOCTOR NOTED THAT A PORTION OF THE VASCU-GUARD WAS ¿FRAYED¿ OR ¿SOMEHOW DEGRADED¿. THE PHYSICIAN WAS NOT ABLE TO RECOVER PIECES OF THE GRAFT AREA. A SECOND VASCU-GUARD PATCH WAS PUT IN PLACE TO RE-ENFORCE THE ORIGINAL PATCH GRAFT SITE, NO ISSUES WERE NOTED. THE PATIENT REMAINED INTUBATED AND TRANSFERRED BACK TO CCU. ADDITIONAL TREATMENT OR INTERVENTIONS WERE NOT REPORTED. AT THE TIME OF THIS REPORT, THE PATIENT OUTCOME WAS NOT REPORTED. NO ADDITIONAL INFORMATION IS AVAILABLE.
Patient problems: Hematoma
MAUDE report 11113445 ↗MalfunctionJul 30, 2020Device Contamination with Chemical or Other Material; Device Contamination with Chemical or Other Material
IT WAS REPORTED THAT A WHITE PARTICULATE MATTER WAS FOUND FLOATING INSIDE THE PACKAGING OF A VASCU-GUARD PATCH. THIS WAS IDENTIFIED DURING SETUP AND PREPARATION PRIOR TO PATIENT USE. THERE WAS NO PATIENT INVOLVEMENT. NO ADDITIONAL INFORMATION IS AVAILABLE.
Patient problems: No Patient Involvement
MAUDE report 10344231 ↗MalfunctionFeb 21, 2020Device Contamination with Chemical or Other Material; Device Contamination with Chemical or Other Material
IT WAS REPORTED THAT HAIR WAS OBSERVED ON A VASCU-GUARD PATCH. THIS ISSUE WAS IDENTIFIED DURING SETUP AND PRIOR TO PATIENT USE. THERE WAS NO PATIENT INVOLVEMENT. NO ADDITIONAL INFORMATION IS AVAILABLE.
Patient problems: No Patient Involvement
MAUDE report 9742341 ↗MalfunctionJan 31, 2019Device Contamination with Chemical or Other Material; Device Contamination with Chemical or Other Material
THIS REPORT SUMMARIZES <NOE> 1 </NOE> MALFUNCTION EVENTS. IT WAS REPORTED THAT THERE WAS A BLACK SPOT ON THE END OF A VASCU-GUARD PATCH. THIS WAS NOTED UPON OPENING THE PACK BEFORE USE. THERE WAS NO PATIENT INVOLVEMENT. NO ADDITIONAL INFORMATION IS AVAILABLE.
Patient problems: No Patient Involvement
MAUDE report 8293039 ↗DeathJun 1, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A PATIENT EXPERIENCED AN ARTERIAL HEMORRHAGE, A NECK HEMATOMA, TRACHEAL COMPRESSION LEADING TO HYPOXIA AND SUBSEQUENT DEATH AFTER UNDERGOING A LEFT CAROTID ENDARTERECTOMY (CEA) IN WHICH A VASCU-GUARD PATCH WAS USED. THERE WERE NO ISSUES NOTED WITH THE PATCH OR WITH BLEEDING INTRAOPERATIVELY. IT WAS REPORTED THAT THE PATIENT TOLERATED THE PROCEDURE WELL AND WAS TRANSFERRED TO THE RECOVERY ROOM IN STABLE CONDITION. APPROXIMATELY ONE AND ONE HALF HOURS AFTER SURGERY, THE PATIENT PASSED AWAY. IT WAS REPORTED THE PATIENT EXPERIENCED A LARGE HEMATOMA THAT WAS COMPRESSING THE TRACHEA CONSISTENT WITH A SUTURE LINE BLOWOUT. PER THE DEATH CERTIFICATE THE PRIMARY CAUSE OF DEATH WAS HYPOXIA, WITH SECONDARY CAUSES LISTED AS COMPRESSION FROM NECK HEMATOMA AND ARTERIAL HEMORRHAGE FOLLOWING CEA. NO ADDITIONAL INFORMATION IS AVAILABLE.
Patient problems: Hematoma; Hemorrhage/Blood Loss/Bleeding; Hypoxia
MAUDE report 7560898 ↗InjuryAug 22, 2016Positioning Problem
BAXTER VASCUGUARD PERIPHERAL PATCH WAS APPLIED DURING AN ENDARTERECTOMY ON (B)(6) 2016. ON (B)(6) 2016, THE PT RETURNED TO THE EMERGENCY DEPARTMENT WITH COMPLAINTS OF NECK SWELLING AT THE SURGICAL SITE. A SURGICAL REVISION WAS PERFORMED. THE PATCH WAS NOT INTACT.
Patient problems: Swelling
MAUDE report 5903577 ↗
Other PATCH, PLEDGET AND INTRACARDIAC, PETP, PTFE, POLYPROPYLENE devices
- CryoPatch® SG Pulmonary Human Cardiac Branch Patch SGP020Artivion, Inc. · Patch, Pledget And Intracardiac, Petp, Ptfe, Polypropylene2 recalls1 report
- Hemashield M002000195140Intervascular Sas · Patch, Pledget And Intracardiac, Petp, Ptfe, Polypropylene1 recall2 reports
- Peri-Guard PC0404NSynovis Life Technologies, Inc. · PATCH, PLEDGET AND INTRACARDIAC, PETP, PTFE, POLYPROPYLENE1 recall0 reports
- Supple Peri-Guard PC0814SNSynovis Life Technologies, Inc. · PATCH, PLEDGET AND INTRACARDIAC, PETP, PTFE, POLYPROPYLENE1 recall0 reports
- SJM™ C0914St. Jude Medical, Inc. · PATCH, PLEDGET AND INTRACARDIAC, PETP, PTFE, POLYPROPYLENE1 recall0 reports
- SJM™ C0510St. Jude Medical, Inc. · PATCH, PLEDGET AND INTRACARDIAC, PETP, PTFE, POLYPROPYLENE1 recall0 reports
- CryoPatch® SG Pulmonary Human Cardiac Hemi-Artery Patch SGPH00Artivion, Inc. · Patch, Pledget And Intracardiac, Petp, Ptfe, Polypropylene1 recall0 reports
- Bard® PTFE Felt Pledgets 007963Bard Peripheral Vascular, Inc. · PATCH, PLEDGET AND INTRACARDIAC, PETP, PTFE, POLYPROPYLENE37 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page